Authors
Latest:
How Will the New FDA COVID-19 Vaccine Policy Affect the Pediatric Population?Pediatrician Sharon Nachman, MD, discusses the potential effects of the new policy including how things like vaccine access, incidence rates, and participation in placebo-controlled trials may change.
Latest:
A Group of Antimicrobial Compounds Show Novelty Action Against Multidrug-Resistant GonorrheaTAXIS Pharmaceuticals Chief Scientific Officer Ajit Parhi, PhD, discusses dihydrofolate reductase inhibitors (DHFRIs) as a novel approach to combat resistant neisseria gonorrhoeae.
Latest:
RSV Prophylaxis: Palivizumab, Nirsevimab, and MoreCurrent prevention strategies include two injectables for infants and young children, namely palivizumab and nirsevimab.
Latest:
Immunocompromised Patients on OPAT Face Nearly Double the Risk of 30-Day ReadmissionChristina Lee, PharmD, and Julia Donahue, PharmD, analyzed 533 encounters revealing a 27.1% readmission rate in immunocompromised patients versus 14.1% in non-immunocompromised patients.
Latest:
The Future and Resources in HCV CareExpert hepatologists discuss future developments in HCV that they are excited about and provide resources for new providers to get started on delivering HCV care.
Latest:
HIV and Long COVID Insights from the RECOVER Program on Risk and DiagnosisKellie Hawkins, MD discusses the findings along with the challenges of diagnosing Long COVID in people with HIV, emphasizing the need for improved clinical recognition and education.
Latest:
A Case of Candida Albicans Ventriculitis Secondary to E Coli Ventriculoperitoneal Shunt InfectionRare cases of health care–associated meningitis and ventriculitis in adults caused by Candida species are associated with recent bacterial meningitis and broad-spectrum antibiotic use.
Latest:
FDA Approves F8 Formulation of Theratechnologies' Tesamorelin for HIV-Associated LipodystrophyTheratechnologies' new tesamorelin formulation provides a simplified, long-acting dosing regimen to effectively manage excess abdominal fat in adults with HIV-associated lipodystrophy.
Latest:
Challenges in the Management of Mycobacterium abscessus ComplexThis pathogen is the third most frequently isolated nontuberculous mycobacteria seen in the United States. Here is a review of how it presents and treatment options.
Latest:
Targeting Soluble gp120 to Combat Immune Dysfunction in People Living with HIVAt CROI 2025, researchers from Université de Montréal discuss how fostemsavir could target residual viral fragments and reduce inflammation.
Latest:
Optimizing ART for Patients With a History of Treatment Failure and ResistanceA review of treatment modalities for this patient population.
Latest:
Lessons in Resilience: What HIV Teaches Us About COVID-19Four lessons learned from the AIDS crisis that can be applied to the fight against our current pandemic.
Latest:
Advice for Physicians to Manage C. Difficile Infection (CDI)Experts share advice for physicians taking care of patients with C. difficile infection (CDI).
Latest:
Sulbactam for Treatment of Carbapenem-Resistant Acinetobacter baumanniiThis is a challenging pathogen, requiring pharmacokinetic and pharmacodynamic considerations; the recent FDA approval of sulbactam-durlobactam offers new hope.
Latest:
The Tripledemic as a Precursor to Stakeholder Alignment under the Quintuple AimInfectious disease outbreaks will continue to increase and trying to find strategies to ensure providers are cared for to prevent burnout and shortage staffing is essential if another pandemic arises.
Latest:
Precision in Practice: PK/PD Modeling Advances Infectious Disease CareAt MAD-ID, Marc Scheetz, PharmD, discusses how PK/PD modeling and AUC-based strategies offer safer, more precise antibiotic therapy.
Latest:
Advocating for Better Regulatory Rules and Standard of Care for C difficileMaryann Webb’s harrowing, personal experience with C diff, along with her professional work with federal agencies has prepared her for a life in advocacy with the Peggy Lillis Foundation. She wants to see the fecal microbiota transplant become more accessible and is working with Congress to make the infection a notifiable infectious disease.
Latest:
Community-Acquired Candida Glabrata Empyema: An Atypical Diagnosis Not to MissAlthough this patient had none of these common risk factors associated with Candida empyema, she did have other factors predisposing her to fungal colonization and subsequent infection.
Latest:
Candida auris: Coming Soon to a Facility Near You?Epidemiologic and clinical lessons for the uninitiated.
Latest:
Tips for Talking with Patients about Fecal Microbiota Transplant for Recurrent C. difficile InfectionsTo close the discussion, experts on C. difficile infections discuss how they talk with patients about fecal microbiota transplantation.
Latest:
Tuberculosis Meningitis in an Immunocompetent PatientRead more about the case of a 71-year-old man who was admitted after presenting with cold-like symptoms for 3 weeks.
Latest:
Deciphering Similarities and Differences in Antifungal and Antibiotic DevelopmentJatin Vyas, PhD, MD, offers some insights into the economics of development, the biology of fungal species, and the difficulties behind creating new antifungal molecules.
Latest:
endTB Trial Paves Way for Shorter, Cheaper, and Safer Rifampin-Resistant TB TreatmentsCarole Mitnick, ScD discusses the impact of the endTB trial's findings on future TB treatment options, including shorter treatment durations, lower costs, and expanded accessibility.
Latest:
How Typhoid Fever Triggers Severe Neurological SymptomsYale researchers have discovered how typhoid fever triggers neurological symptoms, offering new insight into treatment options.
Latest:
An Overview of Cefiderocol Resistance Among Clinical PathogensHere is a review the mechanisms that lead to resistance, including risk factors.
Latest:
Federal Report: Maternal COVID-19 Vaccination Provides Newborn ProtectionNew data demonstrates protection against new variants.
Latest:
STAY PrEPARED: Understanding COVID-19 Pre-Exposure ProphylaxisNew therapeutics offer some hope in this emerging market.
Latest:
Agriculture and Antibiotics: Trying to Protect the Former and Preserve the LatterJennifer Ronholm, PhD, discusses the novel concept of microbiome protection to create healthier animals and reduce antimicrobial usage.
